Detalhe da pesquisa
1.
A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma.
Brief Bioinform
; 22(6)2021 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34237133
2.
m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer.
J Transl Med
; 20(1): 492, 2022 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309694
3.
A panel of eight autophagy-related long non-coding RNAs is a good predictive parameter for clear cell renal cell carcinoma.
Genomics
; 113(2): 740-754, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33516849
4.
circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis.
Mol Cancer
; 20(1): 169, 2021 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34922539
5.
Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancer.
BMC Urol
; 20(1): 100, 2020 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32677927
6.
Overexpression of EIF5A2 in upper urinary tract urothelial carcinoma is a new independent prognostic marker of survival.
Future Oncol
; 15(17): 2009-2018, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30931608
7.
A novel 7-chemokine-genes predictive signature for prognosis and therapeutic response in renal clear cell carcinoma.
Front Pharmacol
; 14: 1120562, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37021054
8.
LZTFL1 inhibits kidney tumor cell growth by destabilizing AKT through ZNRF1-mediated ubiquitin proteosome pathway.
Oncogene
; 42(19): 1543-1557, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36966254
9.
Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study.
Lancet Digit Health
; 5(8): e515-e524, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37393162
10.
TP53/BRAF mutation as an aid in predicting response to immune-checkpoint inhibitor across multiple cancer types.
Aging (Albany NY)
; 14(6): 2868-2879, 2022 03 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35344507
11.
Identification of ZDHHC1 as a Pyroptosis Inducer and Potential Target in the Establishment of Pyroptosis-Related Signature in Localized Prostate Cancer.
Oxid Med Cell Longev
; 2022: 5925817, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36589680
12.
[Corrigendum] Lentivirusmediated RNA interference of clusterin enhances the chemosensitivity of EJ bladder cancer cells to epirubicin in vitro.
Mol Med Rep
; 24(3)2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34212987
13.
Predictive Value of the TP53/PIK3CA/ATM Mutation Classifier for Patients With Bladder Cancer Responding to Immune Checkpoint Inhibitor Therapy.
Front Immunol
; 12: 643282, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34421886
14.
Lentivirus-mediated RNA interference of clusterin enhances the chemosensitivity of EJ bladder cancer cells to epirubicin in vitro.
Mol Med Rep
; 6(5): 1133-9, 2012 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-22895628